Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioTek Delivers Support through Interactive Program

Published: Tuesday, September 12, 2006
Last Updated: Wednesday, September 13, 2006
Bookmark and Share
Qualified customers are introduced to the Winooski, VT facility with a brief plant tour.

BioTek Instruments, Inc. has produced a comprehensive in-house educational and trial research program for its automated microplate technology systems.

Qualified customers are introduced to the Winooski, VT facility with a brief plant tour including manufacturing and quality system areas.

A large portion of the visit is dedicated to technical discussion and hands-on operation in a fully staffed applications laboratory that is tailored to the customer’s unique research.

BioTek staff scientists collaborate with the customer directly on a range of large automated microplate systems and peripheral equipment, including the functional span of features, process validation, and software capacity.

"By inviting prospective customers to our facility, we have the opportunity to focus with them towards a total automated solution without distractions that normally occur in the day-to-day drug discovery laboratory," stated Paul Held, Senior Scientist at BioTek Instruments, Inc.

"In addition to the hands-on research, our entire team of microplate experts is at their disposal to answer any questions about the research process and the critical role of BioTek products within that process."

Peter Weith, Vice President, Marketing & Sales at BioTek Instruments, Inc. highlights the two-sided benefit of this customer participation model, "The customer benefits from a highly educational and hands-on experience in a controlled and focused environment prior to assimilating the equipment in their laboratory."

"And, from our perspective, this program has proven advantageous in further developing our technology within rapidly evolving drug discovery and development markets."

"At the end of the day, we’re always centered on our customers, and we’ll go to great lengths to satisfy their requirements."

"This program allows us to meet their needs today and lay the groundwork to continue meeting their needs well into the future."

Larger robotic systems featured in this program include the Bio-Stack™ Microplate Stacking and Storage System, Bio-Stack™ Twister® II Microplate Handler, and Precision™ Automated Microplate Pipetting Systems.

Complementary equipment includes Synergy™ Multi-Detection Microplate Readers and PowerWave™ Microplate Spectrophotometers (both powered by the new Gen5™ Data Analysis Software), µFill™ and NanoQuot™ Microplate Dispensers, and BioTek’s market-leading ELx405™ Microplate Washers.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioTek Continues International Growth with Launch of BioTek France
BioTek France team includes Dr. Dirk Frese, Philippe Vivier, Damien Brechet and Lionel Capelle.
Wednesday, January 25, 2012
BioTek Offers Service Through Serlabo in France
Serlabo will provide IQ/OQ/PQ, primary training, service, preventative maintenance and service contracts for users of BioTek's microplate instrumentation.
Friday, January 06, 2012
BioTek Recognized with 5x5x5 Award Again
BioTek receives the Award at the 9th annual awards ceremony on Thursday, September 15, 2011.
Saturday, September 17, 2011
BioTek Welcomes New Product Specialist to Cover Expanding Brazilian Market
BioTek Instruments, Inc. welcomes Marcus Stolarski to the company as Product Specialist. Marcus is responsible for supporting BioTek's distribution network and customers in Brazil.
Thursday, March 10, 2011
BioTek Instruments Announces Establishment of Korean Office
Managed by Mr. Yunki Kyung, the new direct sales and service organization will focus on growing BioTek's brand and expanding direct service and application support for our growing customer base in South Korea.
Tuesday, March 01, 2011
BioTek Announces New Applications and Business Development Manager in Canada
Dr Charles Amirmansour is responsible for supporting BioTek's technical and new business activities with Fisher Scientific Canada.
Monday, February 28, 2011
BioTek’s Synergy H1 Receives HTRF Certification
The latest addition to the patent-pending Hybrid Microplate Reader family has received HTRF® certification from Cisbio Bioassays.
Thursday, September 23, 2010
BioTek Instruments and Global Cell Solutions Collaborate at LabAutomation2010
Collaborators announce a new poster detailing the use of BioTek’s microplate instrumentation for various cell-based assays.
Friday, January 29, 2010
BioTek Instruments Launches International Web Sites
Company announces the availability of multi-lingual web sites for international customers.
Thursday, July 30, 2009
Introducing Scientifically Speaking - A Microplate Instrumentation Blog by BioTek Scientists
BioTek scientists are reaching out to the online community through their new blog providing general expertise for microplate instrumentation.
Thursday, July 16, 2009
BioTek Instruments Introduces new Web Site
The new web site, that soon will be available in multiple languages, has improved technical and application resources for life science and drug discovery markets.
Wednesday, February 25, 2009
DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers
The DLR Assay System provides quantitation of firefly and Renilla luciferase reporters in transfected cells.
Wednesday, November 08, 2006
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!